Precursor for future demand? Major industries in Manhattan are receiving optimistic funding so far in 2024
![](/documents/191207401/196751062/db+3.8.24.png/56abc9d4-99b0-3edf-5dd7-40d9ac184fe2?t=1709913726819)
- Office-using industries in Manhattan that have historically relied on venture capital funding have experienced a strong start in 2024.
- In 2023, these top industries secured $36 billion in venture capital funding. Year-to-date in 2024, they have already garnered $21 billion in VC funding, possibly indicating a surge in future demand for office space.
- The substantial funding influx early in 2024 is predominantly attributed to the biotech, life sciences, pharmaceutical, and healthcare sectors. These industries have already attracted $13.8 billion in VC funding, with a significant portion, $13 billion, allocated to Bristol-Myers Squibb.
March 8, 2024
Get market intel
US-NY-NYC New York